Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Brocco, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 29 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Millan, MJ; Brocco, M; Gobert, A; Dorey, G; Casara, P; Dekeyne, A
      Anxiolytic properties of the selective, non-peptidergic CRF1 antagonists, CP154,526 and DMP695: A comparison to other classes of anxiolytic agent

      NEUROPSYCHOPHARMACOLOGY
    2. Millan, MJ; Dekeyne, A; Papp, M; La Rochelle, CD; Macsweeny, C; Peglion, JL; Brocco, M
      S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    3. Millan, MJ; Cussac, D; Milligan, G; Carr, C; Audinot, V; Gobert, A; Lejeune, F; Rivet, JM; Brocco, M; Duqueyroix, D; Nicolas, JP; Boutin, JA; Newman-Tancredi, A
      Antiparkinsonian agent piribedil displays antagonist properties at native,rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. Millan, MJ; Lejeune, F; Gobert, A; Brocco, M; Auclair, A; Bosc, C; Rivet, JM; Lacoste, JM; Cordi, A; Dekeyne, A
      S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    5. Millan, MJ; Dekeyne, A; Rivet, JM; Dubuffet, T; Lavielle, G; Brocco, M
      S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Millan, MJ; Gobert, A; Bervoets, K; Rivet, JM; Veiga, S; Brocco, M
      Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: Roles of multiple monoaminergic receptorsin relation to the actions of antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    7. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Adhumeau, A; Brocco, M; Nicolas, JP; Boutin, JA; Despaux, N; Peglion, JL
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: I. Receptorial, neurochemical, and electrophysiological profile

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    8. Millan, MJ; Brocco, M; Rivet, JM; Audinot, V; Newman-Tancredi, A; Maiofiss, L; Queriaux, S; Despaux, N; Peglion, JL; Dekeyne, A
      S18327 (1-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperid-1-yl]ethyl}3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1) and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine,and 11 other antipsychotic agents

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Millan, MJ; Audinot, V; Honore, P; Bervoets, K; Veiga, S; Brocco, M
      Blockade of NMDA receptors in the nucleus accumbens elicits spontaneous tail-flicks in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Dekeyne, A; Brocco, M; Adhumeau, A; Gobert, A; Millan, MJ
      The selective serotonin (5-HT)(1A) receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats - A comparison with other anxiolytic agents

      PSYCHOPHARMACOLOGY
    11. Millan, MJ; Brocco, M; Gobert, A; Joly, F; Bervoets, K; Rivet, JM; Newman-Tancredi, A; Audinot, V; Maurel, S
      Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat

      EUROPEAN JOURNAL OF NEUROSCIENCE
    12. Millan, MJ; Brocco, M; Gobert, A; Schreiber, R; Dekeyne, A
      S-16924 [(R)-2-{1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl}1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic withmarked serotonin(1A) agonist properties: III. Anxiolytic actions in comparison with clozapine and haloperidol

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    13. AUDINOT V; NEWMANTANCREDI A; GOBERT A; RIVET JM; BROCCO M; LEJEUNE F; GLUCK L; DESPOSTE I; BERVOETS K; DEKEYNE A; MILLAN MJ
      A COMPARATIVE IN-VITRO AND IN-VIVO PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL DOPAMINE D-3 RECEPTOR ANTAGONISTS (-S-14297, NAFADOTRIDE, GR-103,691 AND U-99194())

      The Journal of pharmacology and experimental therapeutics
    14. MILLAN MJ; SCHREIBER R; DEKEYNE A; RIVET JM; BERVOETS K; MAVRIDIS M; SEBBAN C; MAURELREMY S; NEWMANTANCREDI A; SPEDDING M; MULLER O; LAVIELLE G; BROCCO M
      S-16924 YL]-PYRROLIDIN-3YL)-1-(4-FLUORO-PHENYL)-ETHANONE), A NOVEL, POTENTIAL ANTIPSYCHOTIC WITH MARKED SEROTONIN (5-HT)(1A) AGONIST PROPERTIES - II - FUNCTIONAL PROFILE IN COMPARISON TO CLOZAPINE AND HALOPERIDOL

      The Journal of pharmacology and experimental therapeutics
    15. MILLAN MJ; BROCCO M; VEIGA S; CISTARELLI L; MELON C; GOBERT A
      WAY-100,635 ENHANCES BOTH THE ANTIDEPRESSANT ACTIONS OF DULOXETINE AND ITS INFLUENCE ON DIALYSATE LEVELS OF SEROTONIN IN FRONTAL-CORTEX

      European journal of pharmacology
    16. MILLAN MJ; NEWMANTANCREDI A; RIVET JM; BROCCO M; LACROIX P; AUDINOT V; CISTARELLI L; GOBERT A
      S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .1. INTERACTION WITH CLONED HUMAN (H)5-HT1A, DOPAMINE HD(2) HD(3) AND H-ALPHA(2A)-ADRENERGIC RECEPTORS IN RELATION TO MODULATION OF CORTICAL MONOAMINE RELEASE AND ACTIVITY IN MODELS OF POTENTIAL ANTIDEPRESSANT ACTIVITY/

      The Journal of pharmacology and experimental therapeutics
    17. MILLAN MJ; HJORTH S; SAMANIN R; SCHREIBER R; JAFFARD R; DELADONCHAMPS B; VEIGA S; GOUMENT B; PEGLION JL; SPEDDING M; BROCCO M
      S-15535, A NOVEL BENZODIOXOPIPERAZINE LIGAND OF SEROTONIN (5-HT)(1A) RECEPTORS .2. MODULATION OF HIPPOCAMPAL SEROTONIN RELEASE IN RELATION TO POTENTIAL ANXIOLYTIC PROPERTIES

      The Journal of pharmacology and experimental therapeutics
    18. MILLAN MJ; GRESSIER H; BROCCO M
      THE DOPAMINE-D-3-RECEPTOR ANTAGONIST, (-S-14297, BLOCKS THE CATALEPTIC PROPERTIES OF HALOPERIDOL IN RATS())

      European journal of pharmacology
    19. CARRIZO ME; ROMERO JM; MIOZZO MC; BROCCO M; PANZETTA P; CURTINO JA
      BIOSYNTHESIS OF PROTEOGLYCOGEN - MODULATION OF GLYCOGENIN EXPRESSION IN THE DEVELOPING CHICKEN

      Biochemical and biophysical research communications
    20. SCHREIBER R; BROCCO M; DELADONCHAMPS BL; MILLAN MJ
      INVOLVEMENT OF 5-HT1A RECEPTORS IN THE ANXIOLYTIC ACTION OF S-14671 IN THE PIGEON CONFLICT TEST

      Pharmacology, biochemistry and behavior
    21. SCHREIBER R; BROCCO M; DELADONCHAMPS BL; MONNEYRON S; MILLAN MJ
      A DRUG DISCRIMINATION ANALYSIS OF THE ACTIONS OF NOVEL SEROTONIN(1A) RECEPTOR LIGANDS IN THE RAT USING THE 5-HT1A RECEPTOR AGONIST, 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN

      The Journal of pharmacology and experimental therapeutics
    22. MILLAN MJ; PEGLION JL; VIAN J; RIVET JM; BROCCO M; GOBERT A; NEWMANTANCREDI A; DACQUET C; BERVOETS K; GIRARDON S; JACQUES V; CHAPUT C; AUDINOT V
      FUNCTIONAL CORRELATES OF DOPAMINE D-3 RECEPTOR ACTIVATION IN THE RAT IN-VIVO AND THEIR MODULATION BY THE SELECTIVE ANTAGONIST, (-S-14297 .1. ACTIVATION OF POSTSYNAPTIC D-3, RECEPTORS MEDIATES HYPOTHERMIA, WHEREAS BLOCKADE OF D-2 RECEPTORS ELICITS PROLACTIN SECRETION AND CATALEPSY())

      The Journal of pharmacology and experimental therapeutics
    23. MILLAN MJ; RIVET JM; AUDINOT V; GOBERT A; LEJEUNE F; BROCCO M; NEWMANTANCREDI A; MAURELREMY S; BERVOETS K
      ANTAGONIST PROPERTIES OF LY-165,163 AT PRESYNAPTIC AND POSTSYNAPTIC DOPAMINE D-2, D-3, AND D-1 RECEPTORS - MODULATION OF AGONIST ACTIONS AT5-HT1A RECEPTORS IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    24. SCHREIBER R; BROCCO M; AUDINOT V; GOBERT A; VEIGA S; MILLAN MJ
      (1-(2,5-DIMETHOXY-4 IODOPHENYL)-2-AMINOPROPANE)-INDUCED HEAD-TWITCHESIN THE RAT ARE MEDIATED BY 5-HYDROXYTRYPTAMINE (5-HT)(2A) RECEPTORS -MODULATION BY NOVEL 5-HT2A 2C ANTAGONISTS, D-1 ANTAGONISTS AND 5-HT1AAGONISTS/

      The Journal of pharmacology and experimental therapeutics
    25. PEGLION JL; CANTON H; BERVOETS K; AUDINOT V; BROCCO M; GOBERT A; LEMAROUILLEGIRARDON S; MILLAN MJ
      CHARACTERIZATION OF POTENT AND SELECTIVE ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS IN A SERIES OF N4-SUBSTITUTED ARYLPIPERAZINES

      Journal of medicinal chemistry
    26. MILLAN MJ; AUDINOT V; BROCCO M; MAURELREMY S; JOLY F; NEWMANTANCREDI A; CANTON H; HAUTEFAYE P; SPEDDING M; MULLER O; LAVIELLE G
      S-16924 - A PYRROLIDINE-SUBSTITUTED BENZODIOXANE WITH HIGHER AFFINITYAT 5-HT1A 2A/2C THAN D2 RECEPTORS, AND AN ATYPICAL ANTIPSYCHOTIC PROFILE IN THE RAT/

      British Journal of Pharmacology
    27. MILLAN MJ; CANTON H; GOBERT A; LEJEUNE F; RIVET JM; BERVOETS K; BROCCO M; WIDDOWSON P; MENNINI T; AUDINOT V; HONORE P; RENOUARD A; LEMAROUILLEGIRARDON S; VERRIELE L; GRESSIER H; PEGLION JL
      NOVEL BENZODIOXOPIPERAZINES ACTING AS ANTAGONISTS AT POSTSYNAPTIC 5-HT1A RECEPTORS AND AS AGONISTS AT 5-HT1A AUTORECEPTORS - A COMPARATIVE PHARMACOLOGICAL CHARACTERIZATION WITH PROPOSED 5-HT1A ANTAGONISTS

      The Journal of pharmacology and experimental therapeutics
    28. SCHREIBER R; BROCCO M; GOBERT A; VEIGA S; MILLAN MJ
      THE POTENT ACTIVITY OF THE 5-HT1A RECEPTOR AGONISTS, S-14506 AND S-14671, IN THE RAT FORCED SWIM TEST IS BLOCKED BY NOVEL 5-HT1A-RECEPTOR ANTAGONISTS

      European journal of pharmacology
    29. SCHREIBER R; BROCCO M; MILLAN MJ
      BLOCKADE OF THE DISCRIMINATIVE STIMULUS EFFECTS OF DOI BY MDL-100,907AND THE ATYPICAL ANTIPSYCHOTICS, CLOZAPINE AND RISPERIDONE

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 12:07:06